Seeing Is Believing
Pieris Pharmaceuticals's activity chart (see below) currently has 7 price targets and 6 ratings on display.
Analysts average stock forecasts to be materialized ratio is 41.67% with an average time for these price targets to be met of 127.75 days.
Most recent stock forecast was given by ROGER SONG from JEFFERIES on 18-May-2021. First documented stock forecast 05-Aug-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-May-2021
$480
$467.97 (3890.02%)
5 years 5 months 16 days ago
(18-May-2021)
0/1 (0%)
$326.4 (212.50%)
Hold Since 13-Mar-2020
$400
$387.97 (3225.02%)
$400
6 years 7 months 21 days ago
(13-Mar-2020)
3/3 (100%)
$227.2 (131.48%)
209
Buy Since 05-Aug-2016
$720
$707.97 (5885.04%)
$400
6 years 9 months 7 days ago
(27-Jan-2020)
2/3 (66.67%)
$477.6 (197.03%)
302
What is PIRS (Pieris Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PIRS (Pieris Pharmaceuticals)?
Which analyst has the most public recommendations on PIRS (Pieris Pharmaceuticals)?
Which analyst is the currently most bullish on PIRS (Pieris Pharmaceuticals)?
Which analyst is the currently most reserved on PIRS (Pieris Pharmaceuticals)?